Prevalence of Fungal Drug Resistance in COVID-19 Infection: a Global Meta-analysis.

ABSTRACT:

Purpose

Secondary bacterial or fungal infections are one of the most important medical complications among patients with Coronavirus Disease 2019 (COVID-19). The emergence of multidrug-resistant (MDR) candida can cause many problems such as treatment failure, adverse clinical outcomes, and even disease outbreaks. This systematic review and meta-analysis aims to investigate the prevalence and outcomes of fungal drug-resistant in COVID-19 patients.

Methods

PubMed, Embase, Scopus, Cochrane Library, and Web of Science databases were searched for peer reviewed-articles published in English up to May 20, 2021. Heterogeneity across studies was evaluated using Cochrane's Q test and the I² index. The pooled point prevalence and their corresponding 95% confidence intervals

SUBMITTER: Habibzadeh A 

PROVIDER: S-EPMC9376562 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature